当前位置：易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型：会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累，可浏览访问
(41-90)良好信誉积累，可接洽商谈
(91+ )优质信誉积累，可持续信赖
易推广会员：5年
工商认证 【已认证】
最后认证时间：
注册号： 【已认证】
法人代表： 【已认证】
企业类型：生产商 【已认证】
注册资金：人民币万 【已认证】
产品数：86101
参观次数：3573965
自主品牌
已选条件
-
T18561Propargyl-C2-NHS ester；化合物 T18561Propargyl-C2-NHS ester
Propargyl-C2-NHS ester is a nonclaevable linker for antibody-drug-conjugation (ADC).
价 格：￥电议型 号：T18561产 地：中国大陆
-
T18560Propargyl-C1-NHS ester；4-戊炔酸琥珀亚胺酯4-Pentynoic Acid Succinimidyl Ester；4-戊炔酸琥珀亚胺酯|||4-Pentynoic Acid S
Propargyl-C1-NHS ester (4-Pentynoic Acid Succinimidyl Ester) is a nonclaevable linker used for antibody-drug-conjugation (ADC).
价 格：￥电议型 号：T18560产 地：中国大陆
-
T18540Phe-Lys(Trt)-PAB；化合物Phe-Lys(Trt)-PABPhe-Lys(Trt)-PAB
Phe-Lys(Trt)-PAB is a cathepsin-cleavable linker utilized in the development of antibody-drug conjugates (ADCs)[1], serving as a crucial component for facilitating the release of therapeutic agents within targeted cells.
价 格：￥电议型 号：T18540产 地：中国大陆
-
T18539Phe-Lys(Fmoc)-PAB；化合物 T18539Phe-Lys(Fmoc)-PAB
Phe-Lys(Fmoc)-PAB is a cathepsin cleavable ADC linker employed in the conjugation of antibody-drug conjugates (ADCs)[1].
价 格：￥电议型 号：T18539产 地：中国大陆
-
T18515Palbociclib-propargyl；化合物 T18515PROTAC CDK6 ligand 1；PROTAC CDK6 ligand 1
Palbociclib-propargyl, a PROTAC ligand targeting the protein CDK6, connects to the CRBN ligand through a PEG linker to form PROTAC CP-10. CP-10 exhibits a potent DC50 value of 2.1 nM against CDK6[1].
价 格：￥电议型 号：T18515产 地：中国大陆
-
T18514PAC；化合物 T18514PAC
PAC is a chemical conjugate consisting of an ADCs linker and PROTACs linked to an antibody. When PAC is conjugated to an antibody, it exhibits enhanced degradation of estrogen receptor-alpha (ERα) in comparison to PROTAC alone.
价 格：￥电议型 号：T18514产 地：中国大陆
-
T18512OPSS-Val-Cit-PAB-PNP；化合物 T18512OPSS Val Cit PAB PNP|||OPSS-Val-Cit-PAB-PNP|||OPSSValCitPABPNP；OPSS V
OPSS-Val-Cit-PAB-PNP is a cleavable linker employed in ADC (antibody-drug conjugates) synthesis [1].
价 格：￥电议型 号：T18512产 地：中国大陆
-
T18511OPSS-Val-Cit-PAB-OH；化合物 T18511OPSS-Val-Cit-PAB-OH
OPSS-Val-Cit-PAB-OH is an ADC linker utilized for the synthesis of antibody-drug conjugates (ADCs) [1].
价 格：￥电议型 号：T18511产 地：中国大陆
-
T18488NH2-MPAA-NODA；化合物 T18488NH2MPAANODA|||NH2-MPAA-NODA|||NH-2-MPAA-NODA|||NH2 MPAA NODA；NH2MPAANODA|||N
NH2-MPAA-NODA, a nitroveratryl-based photocleavable linker featuring a NODA motif and a methyl phenyl acetic acid (MPAA) backbone, serves as a radiolabel when labeled with 18F-fluoride.
价 格：￥电议型 号：T18488产 地：中国大陆
-
T18475N3-PEG6-Propanehydrazide；化合物 T18475N3-PEG6-Propanehydrazide
N3-PEG6-Propanehydrazide is a polyethylene glycol (PEG) derived linker, specifically designed for use in the synthesis of proteolysis targeting chimeras (PROTACs) [1].
价 格：￥电议型 号：T18475产 地：中国大陆
-
T18473N3-PEG3-vc-PAB-MMAE；化合物 T18473N3PEG3vcPABMMAE|||N3-PEG3-vc-PAB-MMAE|||N-3-PEG3-vc-PAB-MMAE|||N3 PEG3
N3-PEG3-vc-PAB-MMAE, a drug-linker conjugate designed for Antibody-Drug Conjugates (ADC), features the integration of monomethyl auristatin E (MMAE), a tubulin inhibitor, via a 3-unit polyethylene glycol (PEG) linker. This compound demonstrates significant antitumor activity.
价 格：￥电议型 号：T18473产 地：中国大陆
-
T18472N3-PEG3-Propanehydrazide；化合物 T18472N3-PEG3-Propanehydrazide
N3-PEG3-Propanehydrazide serves as a PEG-based PROTAC linker, employed for PROTAC synthesis [1].
价 格：￥电议型 号：T18472产 地：中国大陆
-
T18462N-(Propanoic acid)-N-bis(m-PEG12)；化合物 T18462N-(Propanoic acid)-N-bis(m-PEG12)
N-(Propanoic acid)-N-bis(m-PEG12) is a polyethylene glycol (PEG) based linker for PROTACs synthesis[1].
价 格：￥电议型 号：T18462产 地：中国大陆
-
T18451N-methyl-N’-methyl-O-(m-PEG4)-O’-(propargyl-PEG4)-Cy5；化合物 T18451n-methyl-n-methyl-o-m-peg4-o-proparg
N-methyl-N´-methyl-O-(m-PEG4)-O´-(propargyl-PEG4)-Cy5 is a polyethylene glycol (PEG)-based linker commonly employed in the synthesis of proteolysis-targeting chimeras (PROTACs)[1].
价 格：￥电议型 号：T18451产 地：中国大陆
-
T18450N-methyl-N’-methyl-O-(m-PEG4)-O’-(propargyl-PEG4)-Cy3；化合物 T18450n-methyl-n-methyl-o-m-peg4-o-proparg
N-methyl-N´-methyl-O-(m-PEG4)-O´-(propargyl-PEG4)-Cy3 is a polyethylene glycol (PEG)-based linker used for the synthesis of proteolysis targeting chimeras (PROTACs) [1].
价 格：￥电议型 号：T18450产 地：中国大陆
-
T18432N-(m-PEG4)-N’-(m-PEG4)-O-(m-PEG4)-O’-(propargyl-PEG4)-Cy5；化合物 T18432n-m-peg4-n-m-peg4-o-m-peg4-o-pro
N-(m-PEG4)-N´-(m-PEG4)-O-(m-PEG4)-O´-(propargyl-PEG4)-Cy5 serves as a PEG-based PROTAC linker, facilitating the synthesis of PROTACs[1].
价 格：￥电议型 号：T18432产 地：中国大陆
-
T1838Sapanisertib；沙帕色替TAK-228|||MLN0128|||INK 128；沙帕色替|||TAK-228|||MLN0128|||INK 128
Sapanisertib (INK 128) is an orally bioavailable inhibitor of raptor-mTOR (TOR complex 1 or TORC1) and rictor-mTOR (TOR complex 2 or TORC2) with potential antineoplastic activity.
价 格：￥电议型 号：T1838产 地：中国大陆
-
T18364Tesirine；化合物 T18364MP-PEG8-VA-PABC-PBD Dimer|||Tesirine|||Tesirine|||MP-PEG8-VA-PABC-PBD Dimer|||MP-
MP-PEG8-VA-PABC-PBD Dimer is a drug-linker conjugates for ADC which is used in the treatment of several cancers. PBD Dimer is a DNA alkylating which inhibits DNA replication[1].
价 格：￥电议型 号：T18364产 地：中国大陆
-
T18333mDPR(Boc)-Val-Cit-PAB；化合物 T18333mDPR(Boc)-Val-Cit-PAB
mDPR(Boc)-Val-Cit-PAB is a cleavable linker employed in antibody-drug conjugates (ADCs) [1]. This chemical compound serves as a reliable linker in the formation of ADCs, which are biopharmaceuticals that combine the specificity of monoclonal antibodies with the potency of cytotoxic drugs for targeted cancer therapy [1].
价 格：￥电议型 号：T18333产 地：中国大陆
-
T18332MC-VC-PABC-Aur0101；化合物 T18332MCVCPABCAur0101|||MC-VC-PABC-Aur-0101|||MC VC PABC Aur0101|||MC-VC-PABC
MC-VC-PABC-Aur0101 is a potent anticancer drug-linker conjugate designed for Antibody-Drug Conjugates (ADCs), comprising Aur0101, an auristatin microtubule inhibitor, connected through the MC-VC-PABC linker to enhance antitumor efficacy.
价 格：￥电议型 号：T18332产 地：中国大陆
